Meeting NewsVideo

VIDEO: Similarities seen in PCSK9 inhibitor trials

LAS VEGAS — In this Cardiology Today video exclusive, Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA, director of the Seinsheimer Cardiovascular Health Program and co-director of women’s heart care at the Medical University of South Carolina in Charleston, discusses two presentations on PCSK9 inhibitors presented at the National Lipid Association Scientific Sessions.

Morris discusses the similarities between the ODYSSEY Outcomes and FOURIER sub-analysis trials, and the implications that they will have on future trials of patients who need PCSK9 inhibitors.

Watch the video for more.

LAS VEGAS — In this Cardiology Today video exclusive, Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA, director of the Seinsheimer Cardiovascular Health Program and co-director of women’s heart care at the Medical University of South Carolina in Charleston, discusses two presentations on PCSK9 inhibitors presented at the National Lipid Association Scientific Sessions.

Morris discusses the similarities between the ODYSSEY Outcomes and FOURIER sub-analysis trials, and the implications that they will have on future trials of patients who need PCSK9 inhibitors.

Watch the video for more.

    See more from National Lipid Association Scientific Sessions